Jennifer Nisoy

  • Citations Per Year
Learn More
To the Editor: Since its introduction in the early 1970s, the use of antithymocyte globulin (ATG) has spread widely in the setting of hematopoietic stem cell transplantation (HSCT), mainly for preventing graft-versus-host disease (GVHD) and graft rejection. ATG remains a double-edged sword because it is associated with a delayed immunologic recovery related(More)
  • 1